Lung Cancer
Conference Coverage
Capmatinib shows impressive results in METex14-mutated NSCLC
Capmatinib produced durable responses, even in patients with brain metastases.
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
Feature
Three months of COVID-19 may mean 80,000 missed cancer diagnoses
A backlog of 22 million canceled or postponed tests for five common cancers is expected by early June.
Feature
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
Conference Coverage
Adding a blood test to standard screening may improve early cancer detection
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Conference Coverage
TERAVOLT data suggest high death rate in lung cancer patients with COVID-19
Conference Coverage
Metastatic cancer linked to worse outcomes of COVID-19
From the Journals
Increased risk of lung cancer with COPD, even in never smokers
The highest risk of lung cancer was in patients who had COPD.
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic